Events

Field Safety Notices about Advia Centaur TSH3-Ultra

According to ALIMS (Agencija za lekove i medicinska sredstva), this field safety notices involved a device in Serbia that was produced by SIEMENS HEALTHCARE DIAGNOSTICS INC..

What is this?

Field safety notices are communications sent out by medical device manufacturers or their representatives in relation to actions that they may be taking in relation to their product that is on the market. These are mainly for health workers, but also for users. They can include recalls and alerts.

Learn more about the data here
  • Type of Event
    Field Safety Notice
  • Date
    2013-05-30
  • Event Date Posted
    2013-07-08
  • Event Country
    Serbia
  • Event Source
    ALIMSA
  • Event Source URL
    https://www.alims.gov.rs/latin/2013/08/07/vazno-obavestenje-o-medicinskom-sredstvu-advia-centaur-tsh3-ultra-imunohemija-tireoidni-funkcionalni-markeri/
  • Notes / Alerts
    Serbian data is current through February 2018. All of the data comes from ALIMS (Agencija za lekove i medicinska sredstva), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Serbia.
  • Extra notes in the data
  • Reason
    As part of the study of unexplained inconsistent results, patient samples were identified in which monoclonal antibodies used in the reagents failed to detect the tsh molecule. these individuals may have previously unrecognized, functionally normal tsh variants. the rate of occurrence of this phenomenon over the 30-month period was 0.6 x 10-7.

Device

Advia Centaur TSH3-Ultra

Manufacturer

SIEMENS HEALTHCARE DIAGNOSTICS INC.
  • Manufacturer Parent Company (2017)
    Siemens Ag
  • Source
    ALIMSA